Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pembrolizumab dose per kg?Regulatory approval of unfractionated heparin?Is aimovig a biologic drug?Who is the patent holder of a letrozole?Cost of ivermectin pill?
See the DrugPatentWatch profile for nexlizet
NEXLIZET (a combination of bempedoic acid and ezetimibe) is marketed by Esperion Therapeutics (the drug’s original developer) in the United States.
NEXLIZET is also distributed through regional partners in some countries, but the key U.S. brand seller is Esperion Therapeutics.
Online listings can show different entities depending on what they mean by “seller,” such as: - the marketing authorization holder, - the label holder, - the distributor/pharmacy channel, - or the company shown on a specific website or database record. If you tell me your country (or share the exact website you’re looking at), I can narrow down which company is listed as the “seller” there.
Other Questions About Nexlizet :